Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.
Inaba
M
M
Second Department of Internal Medicine, Osaka City University Medical School, Japan.
Nishizawa
Y
Y
Shioi
A
A
Morii
H
H
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000209:etiology*; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D002117:Calcitriol / Q000494:pharmacology; D002478:Cells, Cultured; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005690:Galactose / Q000008:administration & dosage; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D006934:Hypercalcemia / Q000150:complications*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010006:Osteoblasts / Q000187:drug effects; D010281:Parathyroid Hormone / Q000494:pharmacology; D051381:Rats
D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D010281:Parathyroid Hormone; D000449:Aldehyde Reductase; D002117:Calcitriol; D005947:Glucose; D005690:Galactose